Aclaris Therapeutics, Inc. (ACRS)

NASDAQ

$3.84

$+0.07

(+1.86%)

Regular Market

Aclaris Therapeutics, Inc. (ACRS) Live Price Chart

Last updated: ⁦2026-10-21 19:31:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Aclaris Therapeutics, Inc. (ACRS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.84, with a market capitalization of $512.25M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.03 to $6.60. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$512.25M
Open	$3.74
Day's High	$33.88
Day's Low	$0.59
Previous Close	$3.77
Volume	1.92M
Average Volume	2.77M
P/E Ratio	--
52-Week High	$6.60
52-Week Low	$2.03
Dividend Yield	--
Earnings Date	--

Aclaris Therapeutics, Inc. (ACRS) Stock Price Today

Aclaris Therapeutics, Inc. (ACRS) is currently trading at $3.84 as of 2026-10-21 19:29:00, up 1.72% ($0.06) from the previous close of $3.77

During today's regular trading session, ACRS has traded between $0.59 and $33.88, with a trading volume of 1.92M shares. The current price is near the lower end of today's range.

Aclaris Therapeutics, Inc. (ACRS) 7-Day Stock Price Change

Over the past seven days, Aclaris Therapeutics, Inc. (ACRS) moved from $3.60 to $3.84, representing a gain of 6.53% ($0.23).

The stock traded between $3.25 and $3.97 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 2.82 million shares, down versus the previous seven-day period, indicating lower trading activity.

ACRS 52-Week Price Position

Position in Range: 39.5%

52W Low$2.03

52W High$6.60

ACRS is currently trading at $3.84, placing it 39.5% of the way from its 52-week low of $2.03 to its 52-week high of $6.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Aclaris Therapeutics, Inc. (ACRS)?

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the following key product candidates: Bosakitug (ATI-045), an investigational, novel, humanized anti-TSLP monoclonal antibody being developed for patients with severe asthma, COPD, and chronic rhinosinusitis with nasal polyps; ATI-2138, being developed for the potential treatment of T cell-mediated autoimmune diseases; and ATI-052 and ATI-9494. Additionally, it has an investigational product candidate, Lepzacitinib (ATI-1777), which is being focused upon as a potential treatment for atopic dermatitis and potentially other dermatologic conditions.

Aclaris Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	73
Exchange	NASDAQ
Company Website	https://www.aclaristx.com

How to Buy Aclaris Therapeutics, Inc. (ACRS) Stock on MEXC

Eligible investors can buy real shares of Aclaris Therapeutics, Inc. (ACRS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ACRS and Place Your Order

Open the RealStocks trading page and search for ACRS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Aclaris Therapeutics, Inc. (ACRS) stock price today?

Aclaris Therapeutics, Inc. (ACRS) is currently trading at $ 3.84, up 1.72% ($0.06) from the previous close of $ 3.77. Intraday prices update in real time during regular trading hours.

2.Is ACRS stock going up or down today?

As of 2026-10-21 19:29:00, ACRS is trading at $ 3.84, up 1.72% ($0.06) from its previous close of $ 3.77. The stock has traded between $ 0.59 and $ 33.88 during today’s regular session. Past price movements do not guarantee future results.

3.What is ACRS pre-market price?

As of 2026-10-21 19:29:00, ACRS is trading at $ 3.90 in pre-market trading, up 3.45% ($0.13) from the previous close of $ 3.77. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ACRS after-hours price?

As of 2026-10-21 19:29:00, ACRS is trading at $ 3.75 in after-hours trading, down 0.53% ($0.02) from the regular-session close of $ 3.77. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ACRS stock trading now?

ACRS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ACRS sit relative to its 52-week high and low?

Over the past 52 weeks, ACRS has traded between a low of $ 2.03 and a high of $ 6.60. At $ 3.84, the stock is positioned 39.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Aclaris Therapeutics, Inc. in?

Aclaris Therapeutics, Inc. (ACRS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Aclaris Therapeutics, Inc.'s market capitalization and where is it listed?

Aclaris Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 512.25M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ACRS valued in terms of P/E ratio and EPS?

ACRS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.51. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Aclaris Therapeutics, Inc. pay a dividend?

Aclaris Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.